Infusion Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Infusion Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Therapeutic Area

Report Description

1
1

Infusion therapy is a therapeutic procedure that entails the administration of the medication through sterile needles and catheters. It is prescribed to chronically ill patients and patients that do not respond well to oral medication. It is also prescribed for patients who are unable to take medicine orally. Infusion therapy is widely prescribed for the treatment of chronic and complex diseases such as cardiovascular diseases, cancers, autoimmune diseases, gastrointestinal diseases, respiratory disorders, diabetes, neurological disorders, and various viral & bacterial infections/diseases. Over a period of time, various infusion therapies such as chemotherapy, total parenteral nutritional therapy, and inotropic therapy have been developed. These are found to be effective against a wide range of diseases. Infusion therapy offers several advantages over other non-site-specific delivery methodologies. These include high efficacy, specificity, faster recovery, and easy monitoring. Traditionally, infusion therapy was conducted in a hospital set up. Now, infusion therapy can be carried out at specialty clinics, outpatient infusion therapy centers, and even at home care settings due to the advancements in drug delivery devices.

The global infusion therapy market is estimated to be driven by the high prevalence and rising incidences of chronic as well as acute diseases across the globe. According to World Health Organization, cardiovascular disease is the leading cause of death across the globe; an estimated number of 17.7 million people died globally in 2015. Furthermore, more than 14 million people contracted cancer across the globe in 2012. The number of new cancer cases is estimated to rise by about 70% over the next two decades. New product developments, high clinical and pharmaceutical R&D budgets, rise in number of pipeline products, and increase in demand for blood and blood products are projected to fuel the infusion therapy market during the forecast period. On the other hand, high cost of chemotherapeutic and cardiovascular drugs is likely to restrain the market growth during the forecast period.

The global infusion therapy market can be segmented based on therapy type, disease indication, route of administration, end-user, and geography. In terms of therapy type, the global infusion therapy market can be divided into antibiotic & viral infusion therapy, inotropic therapy, anti-coagulation infusion therapy, chemotherapy, nutritional therapy, anesthesia, blood and blood component infusion therapy, and others. Chemotherapy and inotropic therapy segments are expected to account for the major share of the global infusion therapy market by the end of 2025. In terms of disease indication, the global infusion therapy market can be segregated into cancer, cardiovascular disease, diabetes, infectious disease, inflammatory diseases, arthritis, neurology disorder, nephrology & urological disorder, immune deficiency disorder, pain management, and others. The cardiovascular disease segment is anticipated to hold significant share of the market during the forecast period. The cancer segment can be further sub-divided into lung cancer, breast cancer, blood cancer, colorectal cancer, brain cancer, and other cancers. Based on route of administration, the global infusion therapy market can be split into intravenous, sub-cutaneous, intra muscular, epidural space, and others. In terms of end-user, the market can be classified into hospitals, ambulatory surgery centers, clinics, and home care settings.

In terms of geography, the global infusion therapy market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe and Asia Pacific are projected to dominate the global infusion therapy market by the end of 2025. Significant share of these regions can be ascribed to the high prevalence and rise in incidences of cardiovascular, cancer, and infectious diseases; increase in per capita health care expenditure; and growth in health care access in emerging countries such as India, China, and South Korea. Furthermore, favorable medical reimbursement policies in most countries in European, high clinical R&D budgets, and large base of pharmaceutical and biotechnology companies have contributed to the large share of these regions. The market in Asia Pacific is estimated to expand significantly during the forecast period.

Key players operating in the global infusion therapy market are Johnson & Johnson, GlaxoSmithKline plc, Pfizer Inc., AbbVie Inc., Allergan, Plc., B. Braun Melsungen AG., Fresenius SE & Co. KGaA, Baxter International Inc., Takeda Pharmaceutical Company Limited., Shire Plc, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., CELGENE CORPORATION, Macopharma SA, and Novartis AG. A key trend of merger and acquisition has been observed among the leading players since the last few years.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074